Contact us

Analysis for the determination of a biologic drug’s higher order structure

Designed for the NMR analysis of biotherapeutics, like monoclonal antibodies. 2D NMR spectra of reference samples are compared with that of each test sample using a fingerprinting, or spectral similarity determination.


Download Mnova for a 45-Day Free Trial of Mnova BioHOS

New features

What’s new in Mnova BioHOS 3.0?

  • MCR Tool for Peak Purity Assessment in LCMS Data. (new with Mnova 15.1)
  • PLS Regression: Analyze and predict dependent variables with graphical tools.
  • SIMCA Classification: Supervised data classification method.
  • Enhanced PCA Analysis: Quantile Plots (1D NMR), comparison tool, plot labels, improved interactivity, and more distance options.
  • PROFILE Analysis: Export fingerprint spectra and sync plot crosshairs.
  • CCSD Peaks: Auto-detect reference peaks.
  • Data Preparation: Probabilistic Quotient Normalization (PQN) with result visualization.
Whats-new-Mnova-BioHOS
BioHOS

Benefits

HOS evaluation of medium to high molecular weight species.

Quality Assessment of Biologic drugs using 2D NMR spectral data.

Includes all the «Advanced Chemometrics» capabilities (PCA, PLS, and SIMCA) and 1D Profile, CCSD, and ECHOS.

Signal processing such as compressed sensing, denoising, data alignment, and 2D cross-peak analysis.

Matrix evaluations of all spectra to compare intra- and inter-class samples.

Full automation capabilities that allow the saving and reuse of analysis methods.

BioHOS

Features

New MCR Tool for Peak Purity Assessment in LCMS Data

MCR

New in Mnova 15.1

ECHOS Analysis

CCSD Comparison

PCA Analysis

1D Profile

BioHOS

Videos

Academic, Government & Industrial

Target Audience

Organic Chemists
Researchers
Medicinal Chemists
BIOHOS

Related Products